Statin safety
This article was originally published in The Tan Sheet
Executive Summary
Statin therapy to reduce low-density lipoprotein cholesterol is not associated with an increased risk of cancer, despite previous reports to the contrary, according to a study in the September issue of the Journal of the American College of Cardiology. Researchers led by Alawi Alsheikh-Ali, with the Institute for Clinical Research and Health Policy Studies found through a meta-analysis of 15 randomized controlled trials that "a relationship between on-treatment LDL-C levels and incident cancer was also observed in control populations not treated with statins." Therefore, statin-treated patients lower their LDL-C while maintaining similar risk of cancer as non-statin treated patients, according to the study
You may also be interested in...
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.